Product image of Letybo (Botulinum Toxin Type A) supplied by GNH India

Letybo

Active Ingredient:
Botulinum Toxin Type A
Origin:
EU

Letybo (Botulinum Toxin Type A)

Botulinum toxin type A, the active ingredient in Letybo, is a Botulinum toxin presented as an injectable for intramuscular use. It provides temporary muscle relaxation and is employed to manage spasticity, dystonia, migraine prevention and other neuromuscular conditions.

GNH India supplies Letybo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Croma Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Letybo, a botulinum toxin type A, acts on excessive muscle activity in several neurological and cosmetic indications.

  • Spasticity: reduces muscle tone and improves functional mobility in patients with limb spasticity.
  • Cervical dystonia: alleviates abnormal neck muscle contractions and associated pain.
  • Blepharospasm: diminishes involuntary eyelid closure and improves visual function.
  • Chronic migraine prophylaxis: decreases frequency of migraine attacks in eligible adults.
  • Hyperhidrosis: reduces excessive sweating by blocking sympathetic nerve signals.
  • Cosmetic reduction of facial wrinkles: relaxes facial muscles to smooth dynamic lines.

How It Works

  • Botulinum toxin type A binds to presynaptic nerve terminals at the neuromuscular junction, cleaving SNAP‑25 proteins and preventing acetylcholine vesicle fusion. This inhibition of acetylcholine release leads to a reversible blockade of neuromuscular transmission, resulting in temporary muscle paralysis in the injected area.

Side Effects

Adverse reactions to Letybo are generally related to the injection site and the pharmacologic action of botulinum toxin.

Common Side Effects

  • Injection site pain or tenderness.
  • Localized bruising or erythema.
  • Headache or flu‑like symptoms.
  • Transient weakness of adjacent muscles.
  • Dry mouth or mild dysphagia.

Serious or Rare Side Effects

  • Dysphagia or respiratory compromise due to spread of toxin.
  • Allergic reactions including anaphylaxis.
  • Botulism‑like systemic effects such as generalized weakness.
  • Vision changes or ptosis.
  • Severe muscle weakness beyond the injection site.

Precautions & Warnings

Before using Letybo, consider the following precautions to ensure safe administration.

  • Pregnancy: safety not established; avoid unless benefit outweighs risk.
  • Breastfeeding: unknown excretion; consider potential effects on the infant.
  • Neuromuscular disorders: use with caution as underlying weakness may be exacerbated.
  • Concomitant aminoglycosides or muscle relaxants: monitor for enhanced neuromuscular blockade.
  • Known hypersensitivity to botulinum toxin: contraindicated.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Letybo may interact with other medicines that affect neuromuscular transmission.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics: may potentiate neuromuscular blockade.
  • Quinine: can increase risk of severe muscle weakness.
  • General anesthetics such as succinylcholine: heightened risk of respiratory compromise.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may reduce therapeutic efficacy.
  • Other botulinum toxin products: cumulative effect may increase toxicity.
  • Muscle relaxants (e.g., baclofen): may enhance local weakness.

Frequently Asked Questions

Letybo is indicated for several neuromuscular and cosmetic conditions, including limb spasticity, cervical dystonia, blepharospasm, chronic migraine prevention, primary hyperhidrosis, and the temporary reduction of facial wrinkles caused by muscle activity.

Botulinum toxin type A blocks the release of acetylcholine at the neuromuscular junction by cleaving SNAP‑25 proteins. This prevents nerve signals from triggering muscle contraction, resulting in a reversible, localized paralysis of the targeted muscle fibers.

The appropriate dose of Letybo is set by the prescribing clinician based on the specific indication, severity of the condition, muscle mass involved, and individual patient factors. Dosing is individualized and not standardized across all patients.

Safety data for Letybo in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit justifies the risk, and to consider possible exposure to the infant when breastfeeding.

To order Letybo, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if required) and import documentation.

Letybo contains botulinum toxin type A, the same active class as other commercial preparations such as Botox® and Dysport®. While the core mechanism is identical, differences may exist in formulation, unit potency, diffusion characteristics and approved indications, which can influence clinician preference and dosing strategies.

Letybo should be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the product to maintain stability and potency.

Letybo is administered by a qualified healthcare professional via intramuscular injection. The injection sites and number of units are selected according to the targeted muscle group and the therapeutic indication, following aseptic technique.

Serious risks include spread of toxin effect leading to dysphagia, respiratory compromise, generalized muscle weakness, allergic reactions such as anaphylaxis, and rare botulism‑like systemic symptoms. Prompt medical attention is required if these occur.

Letybo is contraindicated in individuals with a known hypersensitivity to botulinum toxin type A or any of its excipients, and should be used with caution in patients with neuromuscular disorders, pregnant or breastfeeding women, and those taking interacting medications such as aminoglycosides.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Botulinum Toxin Type A

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT